跳至主要内容
临床试验/NCT00795223
NCT00795223已完成4 期

Comparative Effect of 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for Femoral Nerve Block After Total Knee Replacement

Mahidol University1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2008年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
160
试验地点
1
主要终点
Global assessment in post operative pain control

研究概览

简要总结

Comparative efficacy of 24 and 48 hours post operative pain control in single total knee replacement between intrathecal bupivacaine with 0.2 or 0.3 mg morphine together with 0.25 or 0.5 % bupivacaine for single femoral nerve block

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Single elective total knee replacement in ASA 1-3 without significant cardiovascular limitation

排除标准

  • patient at risk in usage COX-2 for post operative pain control

研究组 & 干预措施

1

Active Comparator

Injection of 0.3 mg morphine with spinal block and perform femoral nerve block with 0.5% bupivacaine

干预措施: morphine and bupivacaine (Drug)

2

Active Comparator

Injection of 0.3 mg morphine with spinal block and perform femoral nerve block with 0.25% bupivacaine

干预措施: spinal morphine and marcaine (Drug)

3

Active Comparator

Injection of 0.2 mg morphine with spinal block and perform femoral nerve block with 0.5% bupivacaine

干预措施: morphine and bupivacaine (Drug)

4

Active Comparator

Injection of 0.2 mg morphine with spinal block and perform femoral nerve block with 0.25% bupivacaine

干预措施: morphine and bupivacaine (Drug)

结局指标

主要结局

Global assessment in post operative pain control

时间窗: Begining of first enrollment in december 2008

次要结局

  • Global assessment of post operative pain in 48 HOURS AND SIDE EFFECTS(first enrollment in December 2008)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验